These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 533231)

  • 1. Evaluation of two new assays for determination of serum fibrinogen/fibrin degradation products.
    Sumner K; Feller E; Galanakis DK; Mosesson MW
    Ann Clin Lab Sci; 1979; 9(5):362-7. PubMed ID: 533231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a new anti-fibrinogen-coated latex particle agglutination test in the measurement of serum fibrin degradation products.
    Marder VJ; Cruz GO; Schumer BR
    Thromb Haemost; 1977 Apr; 37(2):183-91. PubMed ID: 577622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of a direct latex-agglutination technic with the tanned red cell hemagglutination inhibition immunoassay (TRCHII) for semiquantitation of fibrinogen/fibrin degradation products.
    Wilson JE; Thornton RD
    Am J Clin Pathol; 1976 Apr; 65(4):528-32. PubMed ID: 1266814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative sensitivity of two hemagglutination inhibition immunoassays for fibrinolytic degradation products in human serum.
    Chi DS; Chen JP
    Thromb Haemost; 1976 Apr; 35(2):423-36. PubMed ID: 823661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The detection of fibrinogen-fibrin degradation products by means of a new antibody-coated latex particle.
    Garvey MB; Black JM
    J Clin Pathol; 1972 Aug; 25(8):680-2. PubMed ID: 5076802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen-fibrin degradation products: hemagglutination inhibition immunoassay in plasma.
    Chi DS; Chen JP
    Tex Rep Biol Med; 1975; 33(4):493-508. PubMed ID: 133472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
    Ito K; Wada H; Abe Y; Tomatsu H; Nishioka J; Nobori T
    Rinsho Byori; 2003 Apr; 51(4):295-9. PubMed ID: 12747249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison between radioimmunoassay and other immunological techniques for the measurement of fibrinogen/fibrin degradation products in serum.
    Ratky SM; Martin MJ; Gordon YB; Baker LR; Chard T; Leslie J
    Br J Haematol; 1975 Jun; 30(2):145-9. PubMed ID: 1201206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products.
    Chen JP; Williams TK; Legendre AM
    Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [FDP (fibrinogen degradation products) determination by TRCHII (tanned red cell haemogglutination inhibition immunoassay) method].
    Abe K; Endo E; Kato M
    Rinsho Byori; 1971 Aug; 19():Suppl:256. PubMed ID: 5290295
    [No Abstract]   [Full Text] [Related]  

  • 11. [Determination of fibrin-fibrinogen degradation products in the serum of newborn infants using a standardized hemagglutination inhibition test (the FDP kit)].
    Weitzel KH; Eschenbach C
    Monatsschr Kinderheilkd; 1984 Jan; 132(1):23-8. PubMed ID: 6700599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of internal hemorrhage on fibrin(ogen) degradation products in canine blood.
    McCaw DL; Jergens AE; Turrentine MA; Johnson GS
    Am J Vet Res; 1986 Jul; 47(7):1620-1. PubMed ID: 3740635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
    Scott WL; Francis CW; Knutson DW; Marder VJ
    J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Methods of determination of fibrin fibrinogen degradation products (review of the literature)].
    Guseínov ChS; Prozorovskaia NN; Mikhaĭlova ND; Gorelova AM; Lagutina NIa
    Lab Delo; 1978; (5):259-66. PubMed ID: 79007
    [No Abstract]   [Full Text] [Related]  

  • 15. Tanned red cell haemagglutination-inhibition immunoassay of fibrinogen-fibrin degradation products.
    Kings GL; Stoodley KD
    Med Lab Sci; 1980 Oct; 37(4):317-22. PubMed ID: 7207041
    [No Abstract]   [Full Text] [Related]  

  • 16. Tanned Red Cell Hemagglutination Inhibition Immunoassay for fibrinogen-fibrin-related antigen ("fibrinolytic degradation products") in human serum.
    Merskey C; Lalezari P; Johnson AJ
    Scand J Haematol Suppl; 1971; 13():83-5. PubMed ID: 5290706
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diagnostic significance of the demonstration of fibrin and fibrinogen degradation products in the urine].
    Bendel M; Oetliker O; Montandon A; Beck EA
    Schweiz Med Wochenschr; 1975 Aug; 105(33):1040-7. PubMed ID: 1099647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular marker for detecting hypercoagulable state].
    Magari Y; Mizunaga S; Ito M; Shibata T; Ito H
    Rinsho Byori; 1994 Jan; 42(1):22-33. PubMed ID: 8107279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of fibrin and fibrinogen split products by their anticoagulant activity].
    Belitser VA; Varetskaia TV; Tsynkalovskaia SN; Tsariuk LA; Shevchenko LI
    Ukr Biokhim Zh; 1976; 48(4):521-32. PubMed ID: 982623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated determination of cross-linked fibrin derivatives in plasma.
    Elms MJ; Bundesen PG; Rowbury D; Goodall S; Wakeham N; Rowell JA; Hillyard CJ; Rylatt DB
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):159-64. PubMed ID: 8457646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.